Literature DB >> 24756834

miR-219 inhibits the proliferation, migration and invasion of medulloblastoma cells by targeting CD164.

Jia-Ang Shi1, Da-Lin Lu2, Xuan Huang3, Wei Tan2.   

Abstract

It is known that microRNA-219 (miR-219) expression is downregulated in medulloblastoma. In the present study, we investigated the expression, targets and functional effects of miR-219 in D283-MED medulloblastoma cells. We first demonstrated that miR-219 not only inhibits proliferation, but also suppresses the invasion and migration of D283-MED cells. Moreover, the knockdown of miR-219 promoted the proliferation, migration and invasion of the D283-MED cells. Secondly, we predicted that miR-219 targets the 3' untranslated region (3'UTR) of CD164 and orthodenticle homeobox 2 (OTX2) and then confirmed that it significantly downregulated the protein expression of CD164 and OTX2 in D283-MED cells. Finally, we demonstrated that the proliferation, invasion and migration of D283-MED cells were promoted by theectopic expression of CD164. These results indicate that miR-219 suppresses the proliferation, migration and invasion of medulloblastoma cells by targeting CD164. The results also suggest that miR-219 may serve as a potential therapeutic agent for medulloblastoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24756834     DOI: 10.3892/ijmm.2014.1749

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  16 in total

1.  MicroRNA-219 exerts a tumor suppressive role in glioma via targeting Sal-like protein 4.

Authors:  Botao Jiang; Min Li; Fang Ji; Yaxiong Nie
Journal:  Exp Ther Med       Date:  2017-10-12       Impact factor: 2.447

2.  Overexpression of CD164 in oral cavity squamous cell carcinoma predicts a favourable prognosis.

Authors:  Jia-Hong Chen; Wei-Liang Chen; James Yi-Hsin Chan; Yuan-Wu Chen; Yi-Jen Peng; Ming-Fang Cheng; Chun-Shu Lin
Journal:  Oncol Lett       Date:  2017-09-15       Impact factor: 2.967

Review 3.  Animal Models to Study MicroRNA Function.

Authors:  Arpita S Pal; Andrea L Kasinski
Journal:  Adv Cancer Res       Date:  2017-08-08       Impact factor: 6.242

4.  Long non-coding RNA TUG1 promotes progression of oral squamous cell carcinoma through upregulating FMNL2 by sponging miR-219.

Authors:  Guangqi Yan; Xue Wang; Mingliang Yang; Li Lu; Qing Zhou
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

Review 5.  miR miR on the wall, who's the most malignant medulloblastoma miR of them all?

Authors:  Xin Wang; Borja L Holgado; Vijay Ramaswamy; Stephen Mack; Kory Zayne; Marc Remke; Xiaochong Wu; Livia Garzia; Craig Daniels; Anna M Kenney; Michael D Taylor
Journal:  Neuro Oncol       Date:  2018-02-19       Impact factor: 12.300

Review 6.  MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons.

Authors:  Tarek Shalaby; Giulio Fiaschetti; Martin Baumgartner; Michael A Grotzer
Journal:  Int J Mol Sci       Date:  2014-11-24       Impact factor: 5.923

7.  Impulsivity and comorbid traits: a multi-step approach for finding putative responsible microRNAs in the amygdala.

Authors:  Andrzej Z Pietrzykowski; Sabine Spijker
Journal:  Front Neurosci       Date:  2014-12-11       Impact factor: 4.677

8.  CD164 regulates proliferation and apoptosis by targeting PTEN in human glioma.

Authors:  Ming Tu; Lin Cai; Weiming Zheng; Zhipeng Su; Yong Chen; Songtao Qi
Journal:  Mol Med Rep       Date:  2017-02-15       Impact factor: 2.952

9.  CD164 promotes lung tumor-initiating cells with stem cell activity and determines tumor growth and drug resistance via Akt/mTOR signaling.

Authors:  Wei-Liang Chen; Ai-Fang Huang; Shih-Ming Huang; Ching-Liang Ho; Yung-Lung Chang; James Yi-Hsin Chan
Journal:  Oncotarget       Date:  2016-08-09

10.  SPARC overexpression alters microRNA expression profiles involved in tumor progression.

Authors:  Bhavesh K Ahir; Nasya M Elias; Sajani S Lakka
Journal:  Genes Cancer       Date:  2017-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.